The U.S. Supreme Court left in place a $65 million antitrust judgment against Martin Shkreli, the “Pharma Bro” who served almost seven years in prison for defrauding investors. The justices without comment turned away Shkreli’s bid to overturn the award …
SACRAMENTO, Calif. (AP)–A company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4,000% after obtaining exclusive rights to the drug, …
A Blue Cross Blue Shield affiliate sued “Pharma Bro” Martin Shkreli, the pharmaceutical industry’s imprisoned enfant terrible, in a Manhattan federal court Thursday, alleging a scheme to monopolize the market for Daraprim, the “gold-standard treatment” for the parasitic infection toxoplasmosis. …